lower schreef op 24 oktober 2016 14:45:
Hoopmazzel bracht t al onder aandacht op een andere draad.
Pharming heeft al eerder convertible bonds uitgegeven.
Pharming obtains Euro 7.5 million financing, Jan 5, 2010
www.fiercebiotech.com/biotech/pharmin...The financing has been structured in the form of a one year (non-listed) convertible debt instrument that is convertible into Pharming shares at Euro 0.50. The debt has a coupon of 9 per cent per annum and is subordinated to the existing Euro 10.9 million convertible bond.
January 16, 2013
Pharming announces EUR16.35 million convertible bond financing
www.marketwired.com/press-release/pha...The bonds will have a fixed conversion price of EUR0.03. The bonds may be redeemed in cash or shares at the option of the Company in seven monthly tranches between March and September 2013 and carry a coupon of 8.5% percent per annum.